The US Preventive Services Task Force (USPSTF) has updated its evidence review and continues to recommend colorectal cancer (CRC) screening for persons between the ages of 50 and 75 to reduce CRC mortality.1 The USPSTF declined, however, to express a preference in screening methods, stating “Multiple screening strategies are available to choose from, with different levels of evidence to support their effectiveness, as well as unique advantages and limitations, although there are no empirical data to demonstrate that any of the reviewed strategies provide a greater net benefit.”1 Nonetheless, the USPSTF evidence review offers an opportunity to compare the benefits and risks of different screening methods, which is the focus of this editorial.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Redberg RF. Fecal Blood Testing or Colonoscopy: What Is the Best Method for Colorectal Cancer Screening? JAMA Intern Med. 2016;176(8):1071–1073. doi:10.1001/jamainternmed.2016.3892
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.